Center for Scientific Review; Notice of Closed Meetings, 5349-5351 [06-919]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 21 / Wednesday, February 1, 2006 / Notices
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Select Bethesda, 8120
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Eliane Lazar-Wesley, PhD.,
Health Scientist Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6101 Executive
Boulevard, Room 220, MSC 8401, Bethesda,
MD 20892–8401, 301–451–4530,
el6r@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse Research
Programs, National Institutes of Health, HHS)
Dated: January 24, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–911 Filed 1–31–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meeting
cchase on PROD1PC60 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel,
NINR Institutional Training (T32) Grant
Applications.
Date: February 7, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: John E. Richters, PhD.,
Scientific Review Administrator, Office of
Review, Division of Extramural Activities,
National Institute of Nursing Research/NIH,
6701 Democracy Blvd., Room 713, MSC
4870, Bethesda, MD 20817, (301) 594–5971,
jrichters@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
VerDate Aug<31>2005
20:20 Jan 31, 2006
Jkt 208001
5349
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: January 24, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–914 Filed 1–31–06; 8:45 am]
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Develop
Methods for Stimulating International
Research Collaborations.
Date: February 1, 2006.
Time: 9 a.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 24, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–915 Filed 1–31–06; 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00118
Fmt 4703
Sfmt 4703
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, T Cell Tolerance.
Date: February 21, 2006.
Time: 3 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
3121, Bethesda, MD 20817, (Telephone
Conference Call).
Contact Person: Paul A. Amstad, PhD.,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, NIH/NIAID/DHHS, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616, (301) 402–7098,
pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transportation Research; 93.856;
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 25, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–916 Filed 1–31–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
E:\FR\FM\01FEN1.SGM
01FEN1
5350
Federal Register / Vol. 71, No. 21 / Wednesday, February 1, 2006 / Notices
cchase on PROD1PC60 with NOTICES
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group, Genetic
Variation and Evolution Study Section.
Date: February 9–10, 2006.
Time: 8:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: The River Inn, 924 25th Street, NW.,
Washington, DC 20037.
Contact Person: David J. Remondini, PhD.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2210,
MSC 7890, Bethesda, MD 20892, 301–435–
1038, remondid@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review and Special Emphasis Panel, Topics
in Bacterial Pathogens.
Date: February 9, 2006.
Time: 9 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Denver International Airport,
Concourse A—Level 4 North, Room 4042,
8500 Pena Boulevard, Denver, CO 80249–
6205.
Contact Person: Joseph D. Mosca, PhD.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5158,
MSC 7808, Bethesda, MD 20892, (301) 435–
2344, moscajos@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group, Somatosensory and
Chemosensory Systems Study Section.
Date: February 14–15, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street, NW., Washington, DC 20037.
Contact Person: Daniel R. Kenshalo, PhD.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5176,
MSC 7844, Bethesda, MD 20892, 301–435–
1255, kenshalod@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Innate
Immunity and Inflammation.
Date: February 16–17, 2006.
Time: 8 a.m. to 5 p.m.
VerDate Aug<31>2005
17:49 Jan 31, 2006
Jkt 208001
Agenda: To review and evaluate grant
applications.
Place: The Watergate, 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: Tina McIntyre, PhD.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4202,
MSC 7812, Bethesda, MD 20892, (301) 594–
6375, mcintyrt@csr.nih.gov.
Name of Committee: Immunology
Integrated Review Group, Cellular and
Molecular Immunology—B Study Section.
Date: February 16–17, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Betty Hayden, PhD.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4206,
MSC 7812, Bethesda, MD 20892, (301) 435–
1223, haydenb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Clinical
Hematology.
Date: February 17, 2006.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Chhanda L. Ganguly, PhD.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7802, Bethesda, MD 20892, (301) 435–
1739, gangulyc@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group, Molecular
Genetics A Study Section.
Date: February 20–21, 2006.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham City Center Hotel, 1143
New Hampshire Ave., NW., Washington, DC
20037.
Contact Person: Michael M. Sveda, PhD.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5152,
MSC 7842, Bethesda, MD 20892, (301) 435–
3565, svedam@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group, Anterior Eye Disease Study Section.
Date: February 20–21, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate, 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: Christine A. Livingston,
PhD., Scientific Review Administrator,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 5202, MSC 7846, Bethesda, MD 20892,
(301) 435–1172, livingsc@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group, Sensorimotor
Integration Study Section.
PO 00000
Frm 00119
Fmt 4703
Sfmt 4703
Date: February 21–22, 2006.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: One Washington Circle Hotel, One
Washington Circle, Washington, DC 20037.
Contact Person: John Bishop, PhD.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5180,
MSC 7844, Bethesda, MD 20892, (301) 435–
1250, bishopj@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group, Central Visual
Processing Study Section.
Date: February 21–22, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Michael A. Steinmetz,
PhD., Scientific Review Administrator,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 5172, MSC 7844, Bethesda, MD 20892,
301–435–1247, steinmem@csr.nih.gov.
Name of Committee: Respiratory Sciences
Integrated Review Group, Respiratory
Integrative Biology and Translational
Research Study Section.
Date: February 21–22, 2006.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Beacon Hotel and Corporate
Quarters, 1615 Rhode Island Avenue, NW.,
Washington, DC 20036.
Contact Person: Everett E. Sinnett, PhD.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2178,
MSC 7818, Bethesda, MD 20892, 301–435–
1016, sinnett@nih.gov.
Name of Committee: Digestive Sciences
Integrated Review Group, Gastrointestinal
Mucosal Pathobiology Study Section.
Date: February 21–22, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Peter J. Perrin, PhD.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, (301) 435–
0682, perrinp@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflicts in Depression and Development
Disorders.
Date: February 21, 2006.
Time: 9 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Dana Jeffrey Plude, PhD.,
Scientific Review Administrator, Center for
E:\FR\FM\01FEN1.SGM
01FEN1
Federal Register / Vol. 71, No. 21 / Wednesday, February 1, 2006 / Notices
cchase on PROD1PC60 with NOTICES
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7848, Bethesda, MD 20892, 301–435–
2309, pluded@csr.nih.gov.
Name of Committee: Respiratory Sciences
Integrated Review Group, Lung Cellular,
Molecular, and Immunobiology Study
Section.
Date: February 22–23, 2006.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham City Center Hotel, 1143
New Hampshire Ave., NW., Washington, DC
20037.
Contact Person: George M. Barnas, PhD.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, 301–435–
0696, barnasg@csr.nih.gov.
Name of Committee: Oncological Sciences
Integrated Review Group, Chemo/Dietary
Prevention Study Section.
Date: February 22–24, 2006.
Time: 5 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Latham Hotel, 3000 M Street, NW.,
Washington, DC 20007.
Contact Person: Sally A. Mulhern, PhD.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6198,
MSC 7804, Bethesda, MD 20892, (301) 435–
5877, mulherns@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group, Neural Basis of Psychopathology,
Addictions and Sleep Disorders Study
Section.
Date: February 22–24, 2006.
Time: 6 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street,
NW., Washington, DC 20036.
Contact Person: Julius Cinque, MS.,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186,
MSC 7846, Bethesda, MD 20892, (301) 435–
1252, cinquej@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS.)
Dated: January 24, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–919 Filed 1–31–06; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
17:49 Jan 31, 2006
Jkt 208001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of an Exclusive
License: ‘‘Vasostatin as Marrow
Protectant’’ and ‘‘Use of Calreticulin
and Calreticulin Fragments To Inhibit
Endothelial Cell Growth and
Angiogenesis and Suppress Tumor
Growth’’
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: This notice, in accordance
with 35 U.S.C. 209(c)(1) and 37 CFR
404.7(a)(1) (i), announces that the
Department of Health and Human
Services is contemplating the grant of an
exclusive license to practice the
inventions embodied in U.S. Patent No.
6,596,690 B2 entitled ‘‘Vasostatin as
Marrow Protectant’’ (HHS Reference E–
230–2000/0); U.S. Patent Application
No. 09/807,148 filed April 5, 2001,
entitled ‘‘Use of Calreticulin and
Calreticulin Fragments To Inhibit
Endothelial Cell Growth and
Angiogenesis and Suppress Tumor
Growth’’ (HHS Reference E–082–1998/
0–US–03); PCT Application No. PCT/
US99/23240 filed October 5, 1999
entitled ‘‘Use of Calreticulin and
Calreticulin Fragments To Inhibit
Endothelial Cell Growth and
Angiogenesis and Suppress Tumor
Growth’’ (HHS Reference E–082–1998/
0–PCT–02); to RxKinetix, Inc. The
patent rights in these inventions have
been assigned to the United States of
America.
The prospective exclusive license
territory may be worldwide and the
field of use may be limited to
development and sale of a
pharmaceutical product useful in
protecting bone marrow stem cells from
the toxic effects of chemotherapy and
radiotherapy.
DATES: Only written comments and/or
license applications which are received
by the National Institutes of Health on
or before April 3, 2006 will be
considered.
ADDRESSES: Requests for copies of the
patent and/or patent applications,
inquiries, comments and other materials
relating to the contemplated exclusive
license should be directed to: Mojdeh
Bahar, J.D., Technology Licensing
Specialist, Office of Technology
Transfer, National Institutes of Health,
6011 Executive Boulevard, Suite 325,
Rockville, MD 20852–3804. Telephone:
(301) 435–2950; Facsimile: (301) 402–
0220; E-mail: baharm@od.nih.gov.
PO 00000
Frm 00120
Fmt 4703
Sfmt 4703
5351
The
technology claimed in the
aforementioned patents is based on the
discovery of the calreticulin N-domain
(vasostatin) and the three previously
uncharacterized properties of
calreticulin. First, calreticulin N-domain
is shown to stimulate the proliferation
and survival in vitro of hematopoietic
cells in the presence of previously
identified growth factors. Second,
Vasostatin is shown to protect
hematopoietic cells in vitro from
toxicity induced by a variety of
chemotherapeutic agents. Third,
Vasostatin is shown to protect a subject
from toxicity to the hematopoietic
system induced by chemotherapy or
irradiation.
The prospective exclusive license will
be royalty-bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless
within sixty (60) days from the date of
this published notice, the NIH receives
written evidence and argument that
establish that the grant of the license
would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR 404.7.
Applications for a license in the field
of use filed in response to this notice
will be treated as objections to the grant
of the contemplated exclusive license.
Comments and objections submitted to
this notice will not be made available
for public inspection and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
This is a modification to the notice
published in 70 FR 96, January 3, 2005.
SUPPLEMENTARY INFORMATION:
Dated: January 23, 2006.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. E6–1389 Filed 1–31–06; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
[Docket No. DHS–2005–0057]
Software Assurance Program: Building
Better Quality and More Secure
Software
National Cyber Security
Division, DHS.
ACTION: Notice of availability.
AGENCY:
SUMMARY: The purpose of this notice is
to inform the public and interested
E:\FR\FM\01FEN1.SGM
01FEN1
]]>Agencies
[Federal Register Volume 71, Number 21 (Wednesday, February 1, 2006)]
[Notices]
[Pages 5349-5351]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-919]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
[[Page 5350]]
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group, Genetic Variation and Evolution Study Section.
Date: February 9-10, 2006.
Time: 8:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: The River Inn, 924 25th Street, NW., Washington, DC
20037.
Contact Person: David J. Remondini, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2210, MSC 7890, Bethesda, MD
20892, 301-435-1038, remondid@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review and Special
Emphasis Panel, Topics in Bacterial Pathogens.
Date: February 9, 2006.
Time: 9 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: Denver International Airport, Concourse A--Level 4 North,
Room 4042, 8500 Pena Boulevard, Denver, CO 80249-6205.
Contact Person: Joseph D. Mosca, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5158, MSC 7808, Bethesda, MD
20892, (301) 435-2344, moscajos@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group, Somatosensory and Chemosensory
Systems Study Section.
Date: February 14-15, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: The Fairmont Washington, DC, 2401 M Street, NW.,
Washington, DC 20037.
Contact Person: Daniel R. Kenshalo, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5176, MSC 7844, Bethesda, MD
20892, 301-435-1255, kenshalod@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Innate Immunity and Inflammation.
Date: February 16-17, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: The Watergate, 2650 Virginia Avenue, NW., Washington, DC
20037.
Contact Person: Tina McIntyre, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4202, MSC 7812, Bethesda, MD
20892, (301) 594-6375, mcintyrt@csr.nih.gov.
Name of Committee: Immunology Integrated Review Group, Cellular
and Molecular Immunology--B Study Section.
Date: February 16-17, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Betty Hayden, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4206, MSC 7812, Bethesda, MD
20892, (301) 435-1223, haydenb@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Clinical Hematology.
Date: February 17, 2006.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: Chhanda L. Ganguly, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118, MSC 7802, Bethesda, MD
20892, (301) 435-1739, gangulyc@csr.nih.gov.
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group, Molecular Genetics A Study Section.
Date: February 20-21, 2006.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: Wyndham City Center Hotel, 1143 New Hampshire Ave., NW.,
Washington, DC 20037.
Contact Person: Michael M. Sveda, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5152, MSC 7842, Bethesda, MD
20892, (301) 435-3565, svedam@csr.nih.gov.
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group, Anterior Eye Disease Study Section.
Date: February 20-21, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: The Watergate, 2650 Virginia Avenue, NW., Washington, DC
20037.
Contact Person: Christine A. Livingston, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5202, MSC 7846, Bethesda, MD
20892, (301) 435-1172, livingsc@csr.nih.gov.
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group, Sensorimotor Integration Study
Section.
Date: February 21-22, 2006.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: One Washington Circle Hotel, One Washington Circle,
Washington, DC 20037.
Contact Person: John Bishop, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5180, MSC 7844, Bethesda, MD
20892, (301) 435-1250, bishopj@csr.nih.gov.
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group, Central Visual Processing
Study Section.
Date: February 21-22, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michael A. Steinmetz, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5172, MSC 7844, Bethesda, MD
20892, 301-435-1247, steinmem@csr.nih.gov.
Name of Committee: Respiratory Sciences Integrated Review Group,
Respiratory Integrative Biology and Translational Research Study
Section.
Date: February 21-22, 2006.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: Beacon Hotel and Corporate Quarters, 1615 Rhode Island
Avenue, NW., Washington, DC 20036.
Contact Person: Everett E. Sinnett, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2178, MSC 7818, Bethesda, MD
20892, 301-435-1016, sinnett@nih.gov.
Name of Committee: Digestive Sciences Integrated Review Group,
Gastrointestinal Mucosal Pathobiology Study Section.
Date: February 21-22, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Peter J. Perrin, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180, MSC 7818, Bethesda, MD
20892, (301) 435-0682, perrinp@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflicts in Depression and Development Disorders.
Date: February 21, 2006.
Time: 9 a.m. to 11 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Dana Jeffrey Plude, PhD., Scientific Review
Administrator, Center for
[[Page 5351]]
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 3192, MSC 7848, Bethesda, MD 20892, 301-435-2309,
pluded@csr.nih.gov.
Name of Committee: Respiratory Sciences Integrated Review Group,
Lung Cellular, Molecular, and Immunobiology Study Section.
Date: February 22-23, 2006.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Wyndham City Center Hotel, 1143 New Hampshire Ave., NW.,
Washington, DC 20037.
Contact Person: George M. Barnas, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180, MSC 7818, Bethesda, MD
20892, 301-435-0696, barnasg@csr.nih.gov.
Name of Committee: Oncological Sciences Integrated Review Group,
Chemo/Dietary Prevention Study Section.
Date: February 22-24, 2006.
Time: 5 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Latham Hotel, 3000 M Street, NW., Washington, DC 20007.
Contact Person: Sally A. Mulhern, PhD., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6198, MSC 7804, Bethesda, MD
20892, (301) 435-5877, mulherns@csr.nih.gov.
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group, Neural Basis of Psychopathology, Addictions
and Sleep Disorders Study Section.
Date: February 22-24, 2006.
Time: 6 p.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: St. Gregory Hotel, 2033 M Street, NW., Washington, DC
20036.
Contact Person: Julius Cinque, MS., Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186, MSC 7846, Bethesda, MD
20892, (301) 435-1252, cinquej@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS.)
Dated: January 24, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-919 Filed 1-31-06; 8:45 am]
BILLING CODE 4140-01-M
